Abstract
While HLA class II alleles identification by means of complement mediated lymphocytotoxicity (serology) is almost replaced by DNA typing techniques, serology is still widely used for routine class I typing. The aim of this prospective study was to compare PCR-based Amplification Refractory Mutation System with serology in clinical HLA class I alleles assignment in patients receiving marrow transplants and their potential donors. The total discrepancy rate in 114 consecutively typed individuals for HLA-A and HLA-C alleles was only in favor of ARMS-PCR, whereas HLA-B typing was discrepant also in favor of serology. The discrepancies were higher in patients, particularily in those with acute lymphoblastic leukaemia, than in healthy individuals. We conclude, that ARMS-PCR is clearly superior to serology in definition of class I alleles, which might be of clinical importance particularly for bone marrow transplantation.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 23 December 1997 / Accepted: 22 June 1998
Rights and permissions
About this article
Cite this article
Usichenko, T., Lattermann, A. & Mueller-Eckhardt, G. Serology versus ARMS-PCR in prospective HLA-class I typing for bone marrow transplantation. Ann Hematol 77, 97–100 (1998). https://doi.org/10.1007/s002770050422
Issue Date:
DOI: https://doi.org/10.1007/s002770050422